RPID — Rapid Micro Biosystems Cashflow Statement
0.000.00%
Last trade - 00:00
- $29.78m
- -$49.46m
- $22.52m
- 25
- 61
- 26
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -21.2 | -37.1 | -73.5 | -60.8 | -52.5 |
Depreciation | |||||
Non-Cash Items | 0.673 | 5.67 | 25 | 4.75 | 3.73 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.11 | -1.1 | -8 | -5.33 | 0.555 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -21.1 | -31 | -55 | -58.5 | -45.1 |
Capital Expenditures | -1.7 | -0.69 | -3.22 | -6.74 | -1.84 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -15 | -10.1 | -86.7 | 44 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -1.7 | -15.7 | -13.3 | -93.5 | 42.2 |
Financing Cash Flow Items | 0 | -2.27 | -1.34 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.9 | 64.2 | 217 | 0.693 | 0.149 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7.97 | 17.6 | 148 | -151 | -2.78 |